Abiopharma

Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders

New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-06-25 AccNo: 0001171843-25-004091 Size: 188 KB Item 8.01: Other Events

New Form 6-K - Concord Medical Services Holdings Ltd Filed: 2025-06-25 AccNo: 0001104659-25-062341 Size: 10 KB

New Form 20-F - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000095 Size: 30 MB

General Announcement: Minutes of Annual General Meeting held on 29 May 2025

New Form 6-K - GSK plc Filed: 2025-06-25 AccNo: 0001654954-25-007374 Size: 1 MB

New Form 8-K - CorMedix Inc. Filed: 2025-06-25 AccNo: 0001213900-25-057451 Size: 196 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Strawberry Fields REIT, Inc. Filed: 2025-06-25 AccNo: 0001641172-25-016353 Size: 211 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - Haleon plc Filed: 2025-06-25 AccNo: 0001654954-25-007372 Size: 35 KB

New Form 6-K - Addex Therapeutics Ltd. Filed: 2025-06-25 AccNo: 0001171843-25-004087 Size: 13 KB

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000093 Size: 50 KB

New Form 4 - Ainos, Inc. Filed: 2025-06-25 AccNo: 0000950103-25-007790 Size: 6 KB

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000091 Size: 21 KB